Evidence map›Paper›PMID 39779675›Full record

ArticleNature communications2025

Predicting cell morphological responses to perturbations using generative modeling.

Alessandro Palma, Fabian J Theis, Mohammad Lotfollahi

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Integrating Biological Knowledge for Robust Microscopy Image Profiling onProceedings. IEEE International Conference on Computer Vision · 2025
    Article
  19. MorphoDiff: Cellular Morphology Painting with Diffusion Models.bioRxiv : the preprint server for biology · 2024
    Article
  20. A mini-review on perturbation modelling across single-cell omic modalities.Computational and structural biotechnology journal · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alessandro PalmaDepartment of Computational Health, Institute of Computational Biology, Helmholtz Zentrum München, Munich, Germany.ORCID http://orcid.org/0000-0002-5190-5278
Fabian J TheisDepartment of Computational Health, Institute of Computational Biology, Helmholtz Zentrum München, Munich, Germany. fabian.theis@helmholtz-munich.de.ORCID http://orcid.org/0000-0002-2419-1943
Mohammad LotfollahiDepartment of Computational Health, Institute of Computational Biology, Helmholtz Zentrum München, Munich, Germany. ml19@sanger.ac.uk.ORCID http://orcid.org/0000-0001-6858-7985

Funding

Wellcome Trust
6 · The paper itself

Abstract

Advancements in high-throughput screenings enable the exploration of rich phenotypic readouts through high-content microscopy, expediting the development of phenotype-based drug discovery. However, analyzing large and complex high-content imaging screenings remains challenging due to incomplete sampling of perturbations and the presence of technical variations between experiments. To tackle these shortcomings, we present IMage Perturbation Autoencoder (IMPA), a generative style-transfer model predicting morphological changes of perturbations across genetic and chemical interventions. We show that IMPA accurately captures morphological and population-level changes of both seen and unseen perturbations on breast cancer and osteosarcoma cells. Additionally, IMPA accounts for batch effects and can model perturbations across various sources of technical variation, further enhancing its robustness in diverse experimental conditions. With the increasing availability of large-scale high-content imaging screens generated by academic and industrial consortia, we envision that IMPA will facilitate the analysis of microscopy data and enable efficient experimental design via in-silico perturbation prediction.

Indexed as

Breast NeoplasmsCell Line, TumorComputer SimulationFemaleHigh-Throughput Screening AssaysHumansImage Processing, Computer-AssistedMicroscopyOsteosarcoma

Identifiers

PMID39779675
PMCPMC11711326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.